ImmunityBio receives five US patents for cancer drug combination

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to ImmunityBio receives five US patents for cancer drug combination
(NASDAQ: IBRX) Delayed: 7.22 -0.14 (1.9%)
Previous Close $7.36    52 Week High $ 
Open $7.49    52 Week Low $ 
Day High $7.55    P/E N/A 
Day Low $7.17    EPS $ 
Volume 9,870,259